Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Norway
  4. Oslo Bors
  5. EXACT Therapeutics AS
  6. News
  7. Summary
    EXTX   NO0010852213

EXACT THERAPEUTICS AS

(EXTX)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

To the shareholders of EXACT Therapeutics AS - NOTICE OF EXTRAORDINARY GENERAL MEETING

11/25/2021 | 12:01pm EST
(English office translation)
To the shareholders of EXACT Therapeutics AS
NOTICE OF EXTRAORDINARY GENERAL MEETING
An Extraordinary General Meeting of EXACT Therapeutics AS, reg. no. 998 317 487,
(the "Company") will be held by way of video conference on 3 December 2021 at
16:00 hours (CET).

The Extraordinary General Meeting will be opened by the Chairperson of the Board
of Directors or a person appointed by her.
The Board of Directors proposes the following agenda:
1	OPENING OF THE EXTRAORDINARY GENERAL MEETING, APPROVAL OF THE SUMMONS AND
AGENDA
2	ELECTION OF CHAIR AND PERSON TO CO-SIGN THE MINUTES
3	ELECTION OF BOARD MEMBER AND REMUNERATION
Hans Henrik Klouman has notified the Company of a need for resignation from the
position as Member of the Board of Directors due to other board commitments.

On this basis, the Nomination Committee proposes that Anders Wold be appointed
as a new board member, to replace Hans Henrik Klouman. The proposal is attached
as Appendix 3.
It is also proposed that Anders Wold shall receive an annualized compensation of
NOK 180,000, in addition to annualized remuneration of NOK 20,000 as member of
the audit committee. The remuneration is paid pro rata for the period between
December 2021 and June 2022, either in cash, as share options (RSUs) or as a
combination of cash and share options (RSUs), as proposed by the nomination
committee and issued by the Board of Directors pursuant to its authorisation at
any given time.
If the Nomination Committee's proposal is resolved, the Board of Directors will
consist of the following board members:
o	Masha Strømme (Chairperson)
o	Sir William Castell (Deputy chair)
o	Jean-Claude Provost
o	Anders Wold 
o	Jean-Michel Cosséry
o	Aitana Peire
o	Ann-Tove Kongsnes
***
EXACT Therapeutics AS has a share capital of NOK 119,968.66 divided on
29,992,165 shares, each with a nominal value of NOK 0.004. Each share carries
one vote at the Extraordinary General Meeting.
Participation:
To ensure that most shareholders will be able to participate and due to the
Covid-19 outbreak, the Extraordinary General Meeting is to be held by video
conference. The Board of Directors considers this as the safest way of holding
the meeting. All participants will need to present a valid ID and documentation
that it can represent the shareholder, if the shareholder is a company.
In order to receive an invitation to the video conference, shareholders wishing
to attend the Extraordinary General Meeting must register, by using the
Attendance Slip attached hereto as Appendix 1, by 2 December 2021 at 11:00 hours
(CET).
The Proxy Form, including detailed instructions for the use of the form, is
enclosed to this notice as Appendix 2. Completed Proxy Forms must be sent to DNB
Bank ASA, Verdipapirservice by e-mail genf@dnb.no prior to 2 December 2021 at
11:00 hours (CET).  
***
Shareholders who attend the Extraordinary General Meeting have the following
rights:
1.	The right to attend the Extraordinary General Meeting by proxy 
(i)	For registration of the proxy, the Proxy Form shall be completed and
submitted to the address set out in the Proxy Form
(ii)	If personal attendance has been registered within the deadline for
registration of attendance on 2 December 2021 at 11:00 (CET), it is still
possible to be represented by proxy if the proxy holder presents a valid and
completed Proxy Form upon registration at the Extraordinary General Meeting
(iii)	If a proxy has been registered within the deadline for registration of
attendance, it is still possible to attend personally and cancel the proxy upon
registration at the Extraordinary General Meeting
(iv)	A proxy may include voting instructions for all or some of the matters on
the Agenda - please use the Voting Form
Proxies to the Chair of the Meeting are registered as voting instructions in
favour of proposals made by the Board of Directors, as well as for the elections
of and remuneration to Members of the Board of Directors, unless otherwise
stated in the voting form.
2. The right to attend the Extraordinary General Meeting personally. For
registration, the Attendance Registration Form shall be completed and submitted
to the Company with the address set out in the Attendance Registration Form
3. The right to be accompanied by one advisor and give him or her the right to
speak at the Extraordinary General Meeting 
4. The right to request information from the Chair of the Board of Directors and
the CEO pursuant to section 5-15 of the Private Limited Liability Companies Act 
5. The right to present alternative proposals within the matters to be resolved
by the Extraordinary General Meeting.

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange

All news about EXACT THERAPEUTICS AS
2021Financial calendar
AQ
2021EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic ..
AQ
2021EXACT Therapeutics AS Awarded NOK 7.4 M Grant for the Development of its Next Generatio..
AQ
2021Exact Therapeutics AS to present at DNB Nordic Healthcare Conference on 16th December 2..
AQ
2021Exact Therapeutics as Appoints Anders Wold to its Board of Directors
CI
2021Exact Therapeutics AS Appoints Prominent Ultrasound And Healthcare Expert To Its Board ..
AQ
2021Exact therapeutics as - mandatory notification of trade by primary insider
AQ
2021Exact Therapeutics AS Minutes From Extraordinary General Meeting - Appointment Of New B..
AQ
2021EXACT Therapeutics AS Announces Board Changes
CI
2021To the shareholders of EXACT Therapeutics AS - NOTICE OF EXTRAORDINARY GENERAL MEETING
AQ
More news
Financials
Sales 2020 - - -
Net income 2020 -33,1 M -3,73 M -3,73 M
Net cash 2020 160 M 18,0 M 18,0 M
P/E ratio 2020 -26,7x
Yield 2020 -
Capitalization 533 M 59,5 M 60,1 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 8
Free-Float -
Chart EXACT THERAPEUTICS AS
Duration : Period :
EXACT Therapeutics AS Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Dominic Michael Moreland Chief Executive & Financial Officer
Masha Paule Nathalie Str°mme Executive Chairman
Andrew John Healey Chief Scientific Officer
Spiros Kotopoulis Chief Technology Officer
Hilary McElwaine-Johnn Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
EXACT THERAPEUTICS AS2.30%60
MODERNA, INC.-39.94%61 847
LONZA GROUP AG-20.30%49 060
IQVIA HOLDINGS INC.-16.27%45 129
SEAGEN INC.-19.08%22 875
ICON PUBLIC LIMITED COMPANY-19.15%20 381